What Happens to GLP-1 Heart Protection When Treatment Stops
If you have followed On The Pen for any length of time, you have heard us talk about the cardiovascular benefits of GLP-1 drugs again and again.
On The Pen GLP-1 News
October 7, 2026 · 1 min read
Members
If you have followed On The Pen for any length of time, you have heard us talk about the cardiovascular benefits of GLP-1 drugs again and again. Wegovy has shown a reduction in major cardiovascular events, the broader GLP-1 class continues to produce cardiovascular signals, and just recently at EASD 2026, Lilly added encouraging heart data for Foundayo,…
Get GLP-1 News Emails
Obesity medicine, decoded daily.
Never miss a news story. Powered by On The Pen's Substack.